Delrue, L.; Muylaert, A.; Beernaert, A.; De Pelsmaeker, I.; Boel, E.; Moya, A.; Verstreken, S.; Dierckx, R.; Heggermont, W.; Bartunek, J.;
et al. T Cell and Antibody Response Following Double Dose of BNT162b2 mRNA Vaccine in SARS-CoV-2 Naïve Heart Transplant Recipients. Diagnostics 2022, 12, 2148.
https://doi.org/10.3390/diagnostics12092148
AMA Style
Delrue L, Muylaert A, Beernaert A, De Pelsmaeker I, Boel E, Moya A, Verstreken S, Dierckx R, Heggermont W, Bartunek J,
et al. T Cell and Antibody Response Following Double Dose of BNT162b2 mRNA Vaccine in SARS-CoV-2 Naïve Heart Transplant Recipients. Diagnostics. 2022; 12(9):2148.
https://doi.org/10.3390/diagnostics12092148
Chicago/Turabian Style
Delrue, Leen, Annelies Muylaert, Ann Beernaert, Imke De Pelsmaeker, Elly Boel, Ana Moya, Sofie Verstreken, Riet Dierckx, Ward Heggermont, Jozef Bartunek,
and et al. 2022. "T Cell and Antibody Response Following Double Dose of BNT162b2 mRNA Vaccine in SARS-CoV-2 Naïve Heart Transplant Recipients" Diagnostics 12, no. 9: 2148.
https://doi.org/10.3390/diagnostics12092148
APA Style
Delrue, L., Muylaert, A., Beernaert, A., De Pelsmaeker, I., Boel, E., Moya, A., Verstreken, S., Dierckx, R., Heggermont, W., Bartunek, J., & Vanderheyden, M.
(2022). T Cell and Antibody Response Following Double Dose of BNT162b2 mRNA Vaccine in SARS-CoV-2 Naïve Heart Transplant Recipients. Diagnostics, 12(9), 2148.
https://doi.org/10.3390/diagnostics12092148
